Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris.

Eichenfield, Lawrence F; Hebert, Adelaide A; Gold, Linda Stein; Cartwright, Martina; Moro, Luigi; Han, Jenny; Squittieri, Nicholas; Mazzetti, Alessandro

Eichenfield, Lawrence F; Hebert, Adelaide A; Gold, Linda Stein; Cartwright, Martina; Moro, Luigi; Han, Jenny; Squittieri, Nicholas; Mazzetti, Alessandro.

J Drugs Dermatol ; 22(8): 810-816, 2023 Aug 01.

Article in En | MEDLINE | ID: mdl-37556524

Subject(s)

Acne Vulgaris; Child; Humans; Acne Vulgaris/diagnosis; Acne Vulgaris/drug therapy; Acne Vulgaris/etiology; Double-Blind Method; Emollients/adverse effects; Erythema/chemically induced; Erythema/diagnosis; Severity of Illness Index; Skin Cream/adverse effects; Treatment Outcome; Adolescent

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acne Vulgaris Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline Limits: Adolescent / Child / Humans Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google